Eley Financial Management Inc increased its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 37,431 shares of the biopharmaceutical company’s stock after purchasing an additional 554 shares during the period. Eley Financial Management Inc’s holdings in […]